دورية أكاديمية
Association of Protein Tyrosine Phosphatase Receptor Type D and Serine Racemase Genetic Variants with Type 2 Diabetes in Malaysian Indians.
| العنوان: | Association of Protein Tyrosine Phosphatase Receptor Type D and Serine Racemase Genetic Variants with Type 2 Diabetes in Malaysian Indians. |
|---|---|
| المؤلفون: | Saif-Ali R; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Sana'a University, Sana'a, Yemen., Al-Hamodi Z; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Sana'a University, Sana'a, Yemen., Salem SD; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Sana'a University, Sana'a, Yemen., Al-Habori M; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Sana'a University, Sana'a, Yemen., Al-Dubai SA; Joint Program of Preventive Medicine, Post Graduate Studies, Medina, Saudi Arabia., Ismail IS; Department of Medicine, Faculty of Medicine, UM, Kuala Lumpur, Malaysia. |
| المصدر: | Indian journal of endocrinology and metabolism [Indian J Endocrinol Metab] 2024 Jan-Feb; Vol. 28 (1), pp. 55-59. Date of Electronic Publication: 2024 Feb 26. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medknow Publications] Country of Publication: India NLM ID: 101555690 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2230-8210 (Print) Linking ISSN: 22309500 NLM ISO Abbreviation: Indian J Endocrinol Metab Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Mumbai, India : Medknow Publications], 1997- |
| مستخلص: | Introduction: Type 2 diabetes (T2D) candidate genes, protein tyrosine phosphatase receptor type D (PTPRD), and serine racemase (SRR) were suggested by a genome-wide association study (GWAS) in the Chinese population. Association studies have been replicated among East Asian populations. The association of PTPRD and SRR genetic variants with T2D in Southeast Asian populations still needs to be studied. This study aimed to investigate the association of PTPRD and SSR genetic variants with T2D in Malaysian Indian subjects. Methods: The single nucleotide polymorphisms (SNPs) of PTPRD (rs649891 and rs17584499) and SRR (rs4523957, rs391300, and rs8081273) were genotyped in 397 T2D and 285 normal Malaysian Indian subjects. Results: The homozygous dominant genotype of rs17584499 is frequent in diabetic patients (56.5%) compared to normal subjects (47.3%). In contrast, the homozygous recessive genotype of rs8081273 is more frequent among normal subjects (12.5%) than diabetic patients (5.6%). The dominant genetic model showed that PTPRD rs17584499 (CC) is a risk factor for T2D (OR = 1.42, P = 0.029), whereas the recessive genetic model showed that SRS SNP rs8081273 was protective for T2D (OR = 0.42, P = 0.003). Conclusion: This study confirmed the association of PTPRD rs17584499 genetic variations with T2D in Malaysian Indians. While the SRR rs8081273 (TT) genotype showed protection against T2D, more investigation in different populations is required to confirm this protection. Competing Interests: There are no conflicts of interest. (Copyright: © 2024 Indian Journal of Endocrinology and Metabolism.) |
| References: | PLoS One. 2018 Apr 4;13(4):e0193515. (PMID: 29617380) Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11686-90. (PMID: 8524829) Front Endocrinol (Lausanne). 2022 Jan 03;12:774696. (PMID: 35046895) J Diabetes Investig. 2014 May 4;5(3):286-9. (PMID: 24843776) Diabetes Res Clin Pract. 2011 May;92(2):e31-3. (PMID: 21281973) J Diabetes Investig. 2013 Mar 18;4(2):168-73. (PMID: 24843648) Clin Endocrinol (Oxf). 2012 Mar;76(3):365-72. (PMID: 21767287) FASEB J. 1995 May;9(8):686-91. (PMID: 7768362) Hum Hered. 2006;61(1):27-30. (PMID: 16534213) Iran J Public Health. 2014 Oct;43(10):1345-55. (PMID: 26060696) J Diabetes Metab Disord. 2021 Jan 20;20(1):131-140. (PMID: 34178825) Eur J Hum Genet. 2012 Aug;20(8):831-6. (PMID: 22333905) Mol Metab. 2017 Apr 08;6(6):459-470. (PMID: 28580277) Oncotarget. 2015 May 30;6(15):12997-3005. (PMID: 26079428) Can J Physiol Pharmacol. 2006 Jul;84(7):755-63. (PMID: 16998539) Diabetes Res Clin Pract. 2012 May;96(2):225-9. (PMID: 22245690) Chin Med J (Engl). 2015 Jul 20;128(14):1873-8. (PMID: 26168825) PLoS One. 2011;6(11):e26953. (PMID: 22096510) Ann Intern Med. 2015 Jun 2;162(11):765-76. (PMID: 25867111) Amino Acids. 1998;15(4):351-61. (PMID: 9891759) Science. 2011 Nov 25;334(6059):1081-6. (PMID: 22116877) Biochem Cell Biol. 2004 Dec;82(6):664-75. (PMID: 15674434) Diabetes Res Clin Pract. 2022 Jan;183:109119. (PMID: 34879977) Mol Metab. 2018 Oct;16:191-202. (PMID: 30093356) Diabetologia. 2011 Aug;54(8):2047-55. (PMID: 21647700) Public Health Genomics. 2021;24(3-4):123-130. (PMID: 33706321) PLoS Genet. 2010 Feb 19;6(2):e1000847. (PMID: 20174558) Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13409-14. (PMID: 10557334) Lancet. 2014 Mar 22;383(9922):1068-83. (PMID: 24315620) |
| فهرسة مساهمة: | Keywords: Genetic variation; risk factors; single-nucleotide polymorphism; type 2 diabetes mellitus |
| تواريخ الأحداث: | Date Created: 20240327 Latest Revision: 20240328 |
| رمز التحديث: | 20240329 |
| مُعرف محوري في PubMed: | PMC10962774 |
| DOI: | 10.4103/ijem.ijem_209_23 |
| PMID: | 38533286 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!